87 related articles for article (PubMed ID: 3849561)
1. [Urinary kallikrein quantity and activity in normal pregnant women in the third trimester].
Hiruta M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1156-60. PubMed ID: 3849561
[TBL] [Abstract][Full Text] [Related]
2. [Urinary kallikrein quantity and activity of normal pregnant women and toxemia patients in third trimester].
Hiruta M; Furuhashi N; Tanaka M; Takahashi T; Kohno H; Suzuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Feb; 38(2):177-80. PubMed ID: 3633950
[TBL] [Abstract][Full Text] [Related]
3. Urinary kallikrein in normal and hypertensive pregnancies.
Elebute OA; Mills IH
Perspect Nephrol Hypertens; 1976; 5():329-38. PubMed ID: 1005045
[TBL] [Abstract][Full Text] [Related]
4. Tissue kallikrein and kininogen levels in fetoplacental tissues from normotensive pregnant women and women with pregnancy-induced hypertension.
Mohamed M; Larmie ET; Singh HJ; Othman MS
Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):15-9. PubMed ID: 17050061
[TBL] [Abstract][Full Text] [Related]
5. Urinary kallikrein excretion in normal and hypertensive pregnancy at term.
Sipilä R; Jalkanen M; Huotari K
Ann Clin Res; 1986; 18(4):208-10. PubMed ID: 3641602
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of urinary kallikrein determination in obstetrics].
Saitoh M; Hada Y; Munakata S; Sada I; Hiraoka T; Nakamura Y; Nomura Y; Shinagawa S
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Feb; 38(2):187-94. PubMed ID: 3457088
[TBL] [Abstract][Full Text] [Related]
7. [Urinary kallikrein levels during pregnancy].
Saitoh M; Munakata S; Sada I; Tanaka S; Ooishi T; Nakamura Y; Nomura Y; Shinagawa S
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):539-46. PubMed ID: 3845954
[TBL] [Abstract][Full Text] [Related]
8. A simple and sensitive method for determination of human urinary kallikrein activity (kininogenase activity), using human low molecular weight kininogen.
Kondo M; Shimamoto K; Ura N; Nishimiya T; Mita T; Nakagawa M; Maeda T; Yamaguchi Y; Iimura O
Endocrinol Jpn; 1984 Oct; 31(5):635-43. PubMed ID: 6569840
[TBL] [Abstract][Full Text] [Related]
9. Purification of human low molecular weight kininogen and its application for a simple ND sensitive method for determination of human urinary kallikrein activity.
Nakagawa M; Shimamoto K; Kondo M; Ura N; Nishitani T; Ishida H; Yokoyama T; Tanaka S; Iimura O
Adv Exp Med Biol; 1986; 198 Pt B():523-9. PubMed ID: 3643739
[TBL] [Abstract][Full Text] [Related]
10. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem).
Rosatelli TB; Roselino AM; Dellalibera-Joviliano R; Reis ML; Donadi EA
Br J Dermatol; 2005 Apr; 152(4):650-7. PubMed ID: 15840094
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.
Maier M; Austen KF; Spragg J
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3928-32. PubMed ID: 6575386
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas.
Proud D; Pierce JV; Pisano JJ
J Lab Clin Med; 1980 Apr; 95(4):563-74. PubMed ID: 6153694
[TBL] [Abstract][Full Text] [Related]
13. Changes in kininogens and kallikrein in the plasma, brain, and uterus during pregnancy in the rat.
Brann DW; Greenbaum L; Mahesh VB; Gao X
Endocrinology; 1995 Jan; 136(1):46-51. PubMed ID: 7828557
[TBL] [Abstract][Full Text] [Related]
14. Measurement of urinary kallikrein acitvity by kinin radioimmunoassay.
Shimamoto K; Tanaka S; Nakao T; Ando T; Nakahashi Y; Sakuma M; Miyahara M
Jpn Circ J; 1979 Mar; 43(3):147-52. PubMed ID: 109645
[TBL] [Abstract][Full Text] [Related]
15. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
[TBL] [Abstract][Full Text] [Related]
16. Estimation of urinary kininogenase activity using bovine serum low molecular weight kininogen.
Abe K; Kato H; Sakurai Y; Itoh T; Saito K; Haruyama T; Otsuka Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120A():105-14. PubMed ID: 495304
[TBL] [Abstract][Full Text] [Related]
17. [Reduction of urinary kallikrein in hypertensive diabetics].
Marre M; Alhenc-Gélas F; Ménard J; Passa P
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):831-4. PubMed ID: 3099698
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
[TBL] [Abstract][Full Text] [Related]
19. Chronic indomethacin administration and its relation with the renal kallikrein kinin system during rat pregnancy.
Oddo EM; Negri AL; Santos JC; Martín RS; Arrizurieta EE
Medicina (B Aires); 1993; 53(4):326-32. PubMed ID: 8201915
[TBL] [Abstract][Full Text] [Related]
20. The excretion of human urinary kallikrein quantity and activity in normal and low renin subgroups of essential hypertension.
Ura N; Shimamoto K; Nakao T; Ogasawara A; Tanaka S; Mita T; Nishimiya T; Iimura O
Clin Exp Hypertens A; 1983; 5(3):329-37. PubMed ID: 6188559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
